Table 3.
Studied Gene/ Location |
FADS1 | FADS2 | FADS3 | SCD | SCD5 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GTA | NC | PA | GTA | NC | PA | GTA | NC | PA | GTA | NC | PA | GTA | NC | PA | ||
FADS1 | GTA | 1.00 | ||||||||||||||
NC | 0.26 | 1.00 | ||||||||||||||
PA | 0.48 * | 0.15 | 1.00 | |||||||||||||
FADS2 | GTA | 0.77 * | 0.09 | 0.51 | 1.00 | |||||||||||
NC | 0.15 | 0.58 * | 0.33 | 0.48 | 1.00 | |||||||||||
PA | 0.22 | 0.10 | 0.48 * | 0.50 * | 0.53 * | 1.00 | ||||||||||
FADS3 | GTA | 0.10 | −0.11 | 0.21 | 0.18 | 0.08 | 0.40 | 1.00 | ||||||||
NC | 0.00 | 0.52 * | −0.01 | 0.14 | 0.21 | 0.37 | 0.40 | 1.00 | ||||||||
PA | −0.10 | −0.03 | 0.43 * | 0.12 | 0.23 | 0.37 | 0.71 * | 0.29 | 1.00 | |||||||
SCD | GTA | 0.58 * | 0.16 | 0.13 | 0.68* | 0.50 | 0.40 | 0.22 | 0.17 | 0.25 | 1.00 | |||||
NC | 0.35 | 0.63 * | 0.04 | 0.38 | 0.45 * | 0.07 | 0.12 | 0.59 * | 0.09 | 0.30 | 1.00 | |||||
PA | 0.20 | 0.35 | 0.46 * | 0.46 | 0.68 * | 0.74 * | 0.35 | 0.49 * | 0.39 | 0.64 * | 0.40 | 1.00 | ||||
SCD5 | GTA | 0.65 * | −0.07 | 0.48 * | 0.82 * | 0.35 | 0.52 * | 0.03 | −0.05 | −0.05 | 0.56 * | 0.20 | 0.57 * | 1.00 | ||
NC | 0.30 | 0.66 * | 0.37 | 0.51 * | 0.80 * | 0.65 * | 0.05 | 0.42 | 0.25 | 0.52 * | 0.63 * | 0.76 * | 0.48 | 1.00 | ||
PA | 0.47 * | 0.21 | 0.55* | 0.68 * | 0.62 * | 0.70 * | 0.16 | 0.08 | −0.02 | 0.24 | 0.22 | 0.59 * | 0.65 * | 0.71 * | 1.00 |
The values of Spearman’s rank correlation coefficients are given. * statistically significant correlation of the expression of two genes/locations (p < 0.05). GTA—growing tumor area; NC—necrotic core; PA—peritumoral area.